{
    "organizations": [],
    "uuid": "4c5b9536ae05f6524c93e9ab15ad5a5b5fbf73a3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-roche-drugs-chief-says-erosion-in/brief-roche-drugs-chief-says-erosion-in-european-rituxan-sales-to-intensify-in-2018-as-biosimilars-enter-more-markets-after-26-percent-4th-quarter-drop-idUSFWN1PR15Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Roche Drugs Chief Says Erosion In European Rituxan Sales To Intensify In 2018 As Biosimilars Enter More Markets After 26 Percent 4th Quarter Drop",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1 (Reuters) - Roche:\n* DRUGS CHIEF SAYS EROSION IN EUROPEAN RITUXAN SALES TO INTENSIFY IN 2018 AS BIOSIMILARS ENTER MORE MARKETS AFTER 26 PERCENT 4TH QUARTER DROP Source text for Eikon: Further company coverage: (Reporting by John Miller)\n ",
    "published": "2018-02-02T00:41:00.000+02:00",
    "crawled": "2018-02-01T19:19:02.026+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "roche",
        "drug",
        "chief",
        "say",
        "erosion",
        "european",
        "rituxan",
        "sale",
        "intensify",
        "biosimilars",
        "enter",
        "market",
        "percent",
        "4th",
        "quarter",
        "drop",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "john",
        "miller"
    ]
}